Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) has reported Asset Utilization Ratio for 18 consecutive years, with 0.43 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Utilization Ratio rose 11.26% year-over-year to 0.43; the trailing twelve-month figure through Jun 2026 stood at 0.43 (up 11.26% YoY), and the FY2025 full-year result was 0.43, up 7.87% from the prior year.
• Asset Utilization Ratio advanced to 0.43 in Q2 2026 per TEVA's latest filing, from 0.43 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.43 in Q2 2026 and bottomed at 0.33 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.37 across 5 years, with a median of 0.37 in 2024.
• The widest YoY moves for Asset Utilization Ratio: up 14.1% in 2025, down 4.32% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.34 in 2022, then grew by 9.5% to 0.37 in 2023, then increased by 1.33% to 0.38 in 2024, then increased by 14.1% to 0.43 in 2025, then rose by 1.22% to 0.43 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.43, 0.43, and 0.43 for Q2 2026, Q1 2026, and Q4 2025 respectively.